The needle-free injection system is a new approach to introduce various type of medicine into patient’s blood circulation. This technology has emerged as a safer, less painful and cost-effective alternative. The needle-free injection system delivers the drug through the skin using forces such as Lorentz, shock waves, pressure by gas, and electrophoresis. Moreover, strong demand for needle-free injection system is due to its emerging applications in biosimilar, vaccination, and local anesthetics. Furthermore, technological advancements in the needle-free injection system owing to increasing research and development activities are further expected to fuel the demand during the forecast period.

Geographically, North America held the major share of the global needle free injection system market in 2017. The growth in the region is attributed to the increasing prevalence of chronic diseases and growing demand for self-injection devices. The growth of needle free injection system market in Europe is primarily attributed to growing government support for product approvals. Asia-Pacific is expected to witness the highest CAGR during the forecast period due to high incidence of needle stick injuries, and rapid technological advancements in drug delivery devices in the region.

Some of the key companies operating in the Market include PharmaJet, Antares Pharma, Inc., European Pharma Group, Crossject needle-free injection systems, AkraDermojet, Enable Injections, 3M Company, Penjet Corporation, Zogenix, Inc., B. Braun Melsungen AG, and Valeritas,Inc. among others.

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology

1.2. Research scope & assumptions

1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Needle Free Injection System- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition

3.2. Market segmentation

3.3. Key findings of the global needle free injection system market

3.4. Value chain analysis

3.5. Market opportunities & trends

3.5.1. Increasing awareness among people regarding the benefits of needle free injection system

3.5.2. Potential usage in emerging biological medicines

3.6. Market driver analysis

3.6.1. Increasing demand for self-injection devices

3.6.2. Growing demand for vaccination

3.6.3. Increasing incidence of needle stick injuries

3.6.4. Increasing prevalence of chronic diseases

3.7. Market restraint analysis

3.7.1. Presence of substitute product in the market

3.8. Industry Analysis-Porters five forces of analysis

CHAPTER 4. Competitive Outlook

4.1. Company share analysis

4.2. Competitive factors

4.3. Strategies adopted

CHAPTER 5. Global Needle Free Injection System Market Size and Forecast (2014 – 2024)

5.1. Global Needle Free Injection System Market, By Type (USD Million)

5.1.1. Powder-Based Needle Free Injectors

5.1.2. Liquid-Based Needle Free Injectors

5.1.3. Depot-Based Needle Free Injectors

5.2. Global Needle Free Injection System Market, By Product (USD Million)

5.2.1. Prefilled Needle Free Injectors

5.2.2. Fillable Needle Free Injectors

5.3. Global Needle Free Injection System Market, By Technology (USD Million)

5.3.1. Transdermal Patch Technology

5.3.2. Inhaler Technology

5.3.3. Jet Injectors

5.3.4. Novel Needle Free Technologies

5.4. Global Needle Free Injection System Market, By Usability (USD Million)

5.4.1. Reusable Needle Free Injectors

5.4.2. Disposable Needle Free Injectors

5.5. Global Needle Free Injection System Market, By Site of Delivery (USD Million)

5.5.1. Subcutaneous Injectors

5.5.2. Intradermal Injectors

5.5.3. Intramuscular Injectors

5.6. Global Needle Free Injection System Market, By Application (USD Million)

5.6.1. Pain management

5.6.2. Pediatric injections

5.6.3. Vaccine delivery

5.6.4. Oncology

5.6.5. Insulin delivery

5.6.6. Others

5.7. Global Needle Free Injection System Market, By End-User (USD Million)

5.7.1. Hospitals

5.7.2. Research Laboratories

5.7.3. Home Care Settings

CHAPTER 6. Global Needle Free Injection System Market, By Geography

6.1. North America Needle Free Injection System Market

6.1.1. North America Needle Free Injection System Market, By Type (USD Million)

6.1.2. North America Needle Free Injection System Market, By Product (USD Million)

6.1.3. North America Needle Free Injection System Market, By Technology (USD Million)

6.1.4. North America Needle Free Injection System Market, By Application (USD Million)

6.1.5. North America Needle Free Injection System Market, By Usability (USD Million)

6.1.6. North America Needle Free Injection System Market, By Site of Delivery (USD Million)

6.1.7. North America Needle Free Injection System Market, By End-User (USD Million)

6.1.8. North America Needle Free Injection System Market, By Country

   6.1.8.1. United States

   6.1.8.2. Canada

   6.1.8.3. Mexico

6.2. Europe Needle Free Injection System Market

6.2.1. Europe Needle Free Injection System Market, By Type (USD Million)

6.2.2. Europe Needle Free Injection System Market, By Product (USD Million)

6.2.3. Europe Needle Free Injection System Market, By Technology (USD Million)

6.2.4. Europe Needle Free Injection System Market, By Application (USD Million)

6.2.5. Europe Needle Free Injection System Market, By Usability (USD Million)

6.2.6. Europe Needle Free Injection System Market, By Site of Delivery (USD Million)

6.2.7. Europe Needle Free Injection System Market, By End-User (USD Million)

6.2.8. Europe Needle Free Injection System Market, By Country

   6.2.8.1. United Kingdom

   6.2.8.2. France

   6.2.8.3. Germany

   6.2.8.4. Italy

   6.2.8.5. Austria

   6.2.8.6. Russia

   6.2.8.7. Rest of Europe

6.3. Asia-Pacific Needle Free Injection System Market

6.3.1. Asia-Pacific Needle Free Injection System Market, By Type (USD Million)

6.3.2. Asia-Pacific Needle Free Injection System Market, By Product (USD Million)

6.3.3. Asia-Pacific Needle Free Injection System Market, By Technology (USD Million)

6.3.4. Asia-Pacific Needle Free Injection System Market, By Application (USD Million)

6.3.5. Asia-Pacific Needle Free Injection System Market, By Usability (USD Million)

6.3.6. Asia-Pacific Needle Free Injection System Market, By Site of Delivery (USD Million)

6.3.7. Asia-Pacific Needle Free Injection System Market, By End-User (USD Million)

6.3.8. Asia-Pacific Needle Free Injection System Market, By Country

   6.3.8.1. Japan

   6.3.8.2. China

   6.3.8.3. India

   6.3.8.4. Australia

   6.3.8.5. Rest of Asia-Pacific

6.4. Central & South America Needle Free Injection System Market

6.4.1. Central & South America Needle Free Injection System Market, By Type (USD Million)

6.4.2. Central & South America Needle Free Injection System Market, By Product (USD Million)

6.4.3. Central & South America Needle Free Injection System Market, By Technology (USD Million)

6.4.4. Central & South America Needle Free Injection System Market, By Application (USD Million)

6.4.5. Central & South America Needle Free Injection System Market, By Usability (USD Million)

6.4.6. Central & South America Needle Free Injection System Market, By Site of Delivery (USD Million)

6.4.7. Central & South America Needle Free Injection System Market, By End-User (USD Million)

6.4.8. Central & South America Needle Free Injection System Market, By Country

   6.4.8.1. Brazil

   6.4.8.2. Argentina

   6.4.8.3. Rest of Central & South America

6.5. Middle East and Africa Needle Free Injection System Market

6.5.1. Middle East and Africa Needle Free Injection System Market, By Type (USD Million)

6.5.2. Middle East and Africa Needle Free Injection System Market, By Product (USD Million)

6.5.3. Middle East and Africa Needle Free Injection System Market, By Technology (USD Million)

6.5.4. Middle East and Africa Needle Free Injection System Market, By Application (USD Million)

6.5.5. Middle East and Africa Needle Free Injection System Market, By Usability (USD Million)

6.5.6. Middle East and Africa Needle Free Injection System Market, By Site of Delivery (USD Million)

6.5.7. Middle East and Africa Needle Free Injection System Market, By End-User (USD Million)

6.5.8. Middle East and Africa Needle Free Injection System Market, By Region

   6.5.8.1. Saudi Arabia

   6.5.8.2. South Africa

   6.5.8.3. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments

7.1. PharmaJet

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. Antares Pharma, Inc.

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. European Pharma Group

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. Crossject needle-free injection systems

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. Akra Dermojet

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. Enable Injections

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. 3M Company

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. Penjet Corporation

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. Zogenix, Inc.

7.9.1. Business Overview

7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. B. Braun Melsungen AG

7.10.1. Business Overview

7.10.2. Product and Service Offering

7.10.3. Financial Overview

7.10.4. Strategic Developments

7.11. Valeritas. In

7.11.1. Business Overview

7.11.2. Product and Service Offering

7.11.3. Financial Overview

7.11.4. Strategic Developments

7.12. Abbreviation